Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03730272
Other study ID # Trauma.pain.Gyda
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2018
Est. completion date November 1, 2019

Study information

Verified date November 2018
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To register the perceived pain score during 0-14 days after multitrauma in conscious patients and to register the use (type and dose) of analgesic treatment in the same period.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date November 1, 2019
Est. primary completion date March 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Patient With trauma, ISS > 8

Exclusion Criteria:

- Unconscious patients at admission

- patients due for major surgery within 3 hrs of admission

- patients primary admitted to other hospitals

- not able to communicate in Norewegian

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
analgesic drugs and methods
the patient will receive analgesic treatment at the discretion of the physician in charge

Locations

Country Name City State
Norway Dept of Anesthesiology, Oslo University Hospital, Ullevaal Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Worst pain NRS scale, 0-10 0-14 days
Primary Average pain NRS scale, 0-10 0-14 days
Secondary analgesic methods list of drugs (dose and duration) and other analgesic measures 0-14 days
See also
  Status Clinical Trial Phase
Completed NCT01123551 - Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain Phase 3